Gilead Sciences (GILD) Assets Average (2009 - 2026)

Gilead Sciences (GILD) posted Assets Average of $57.7 billion for Q1 2026, down 1.92% quarter-over-quarter from $58.8 billion in Q4 2025, and little changed year-on-year from $57.7 billion in Q1 2025.

Gilead Sciences (GILD) Assets Average (2009 - 2026) Analysis & Trends

Gilead Sciences (GILD) has reported Assets Average for 18 consecutive years, with $57.7 billion the latest figure, recorded in Q1 2026.

  • Assets Average for Q1 2026 came in at $57.7 billion, changed 0.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $57.7 billion (changed 0.11% YoY), and the FY2025 annual result was $59.0 billion, down 2.56% from the prior year.
  • Assets Average was $57.7 billion for Q1 2026 at Gilead Sciences, down from $58.8 billion in the prior quarter.
  • Over five years, Assets Average peaked at $65.5 billion in Q1 2022 and troughed at $54.1 billion in Q3 2024.
  • Average Assets Average over 5 years is $59.7 billion, with a median of $59.2 billion recorded in 2024.
  • Year-over-year, Assets Average dropped 13.32% in 2024 and gained 5.69% in 2025.
  • Over 5 years, Assets Average stood at $62.9 billion in 2022, then dropped by 0.98% to $62.2 billion in 2023, then fell by 8.82% to $56.8 billion in 2024, then advanced by 3.56% to $58.8 billion in 2025, then decreased by 1.92% to $57.7 billion in 2026.
  • Per Business Quant data, the three most recent Assets Average figures were $57.7 billion in Q1 2026, $58.8 billion in Q4 2025, and $57.1 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 114.53 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 200.05 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 135.21 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 114.04 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 132.78 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 91.55 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 57.65 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 208.08 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn 29.46 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 57.65 Bn
Dec 31, 2025 58.78 Bn
Sep 30, 2025 57.13 Bn
Jun 30, 2025 56.08 Bn
Mar 31, 2025 57.71 Bn
Dec 31, 2024 56.76 Bn
Sep 30, 2024 54.05 Bn
Jun 30, 2024 54.94 Bn
Mar 31, 2024 59.21 Bn
Dec 31, 2023 62.25 Bn
Sep 30, 2023 62.36 Bn
Jun 30, 2023 62.11 Bn
Mar 31, 2023 62.52 Bn
Dec 31, 2022 62.86 Bn
Sep 30, 2022 62.71 Bn
Jun 30, 2022 62.98 Bn
Mar 31, 2022 65.52 Bn
Dec 31, 2021 67.53 Bn
Sep 30, 2021 67.54 Bn
Jun 30, 2021 67.74 Bn